Nivf 2025 forecast

NewGenIVF Group (NIVF) does not currently have a 2025 forecast available.

1. No Forecast Data: There is no financial data available for NIVF's forecast price in 2025. The latest available data is from October 23, 2024, which shows a closing price of $1.03 per share.
2. Insufficient Analyst Coverage: There is no consensus rating or price target available from analysts for NIVF. This makes it difficult to provide a reliable forecast for the company's future performance.
3. Recent Performance and Analyst Sentiment: NIVF has shown volatility in its stock price, with a beta of 0.29 indicating that its share price is 71% less volatile than the S&P 500. However, the company has lower revenue but higher earnings than Marpai, as reported by MarketBeat.
4. Technical Indicators: The technical indicators for NIVF are RSI 55.79, MACD 0.06, and KDJ 15.15. These indicators suggest that the stock is neither overbought nor oversold, and the recent price action has been relatively neutral.
5. Bollinger Bands: The Bollinger Bands for NIVF are $1.57, $0.87, and $0.16 respectively. This indicates that the stock has a relatively narrow range of potential prices in the near term, which could be indicative of lower volatility.
6. Moving Averages: The stock's 5-Day, 10-Day, and 20-Day moving averages are $1.15, $1.13, and $0.89 respectively, while the 30-Day, 50-Day, and 60-Day moving averages are $0.81, $0.82, and $0.83 respectively. The 120-Day, 200-Day, and 250-Day moving averages are $0.96, $3.82, and $5.23 respectively. The proximity of the short-term and long-term moving averages suggests that the stock is in a consolidation phase.
7. Valuation Ratios: The P/E(TTM) ratio is 92.77, the Price to Book Ratio is 11.67, and the P/S ratio is 2.35. These ratios suggest that the company may be valued较高，可能需要时间来实现盈利增长以证明其当前估值的合理性。
8. Recent Business Combination: NewGenIVF Group completed a business combination with A SPAC I Acquisition Corp., which may impact its future performance. However, specific financial forecasts are not currently available.

In conclusion, while there are some positive indicators for NIVF, such as its lower volatility and higher earnings compared to Marpai, there is currently no reliable forecast data available for NIVF in 2025. Investors may need to rely on historical performance and technical indicators to make informed decisions about the stock.